Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:263871.
doi: 10.5402/2012/263871. Epub 2012 Jun 18.

PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?

Affiliations

PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?

Narges Moslemi Zadeh et al. ISRN Obstet Gynecol. 2012.

Abstract

Background. Preeclampsia affects 5-6% of all pregnancies. Predictive factors of preeclampsia can be helpful in early diagnosis of this disease. In this study the predictive values of biochemical markers placenta protein 13 (PP13) and pregnancy-associated plasma protein A (PAPP-A) have been assessed in early diagnosis of preeclampsia. Methods. This case-control study was conducted on 1500 women who presented to a healthcare center of Sari, Iran, between 2010 and 2011. Blood samples were drawn in weeks 11-13 and 24-28 of pregnancy. Of them who developed preeclampsia were considered as case group. A control group consisted of similar women regarding mean age, body mass index (BMI), and pregnancy age. PAPP-A and PP13 serum levels were measured. Data were analyzed using proper statistical tests. Results. PAPP-A and PP13 serum levels were significantly lower in both the first and second trimesters in women who developed preeclampsia (P < 0.001). The cumulative value of all four variables with cut-off point of 238.5 has sensitivity, specificity of 91.0%, and undercurve surface of 0.968 which is the most diagnostic value for preeclampsia. Conclusion. It is possible to advantage measuring of PAPP-A and PP13 in the first and second trimesters especially their cumulative values in both trimesters for prediction of the incidence of preeclampsia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Frequency of mild and severe preeclampsia.

Similar articles

Cited by

References

    1. Heilmannl L, Seikmann U. Hemodynamic and hemorhological profiles in women with proteinuric hypertension og pregnancy and in pregnant controls. Archives of Gynecology and Obstetrics. 1998;246(3):159–168. - PubMed
    1. Chomian N. Investigation of during of activity phase and method delivering in primipar with preeclampsia. Raze Behzistan. 2003;10(4):6–9.
    1. Chaftez I, kuhnreich I, Smmar M, et al. First trimester Placental protein 13 screening for preeclampsia and intra uterin growth restriction. American Journal of Obstetrics and Gynecology. 2007;197(1):35–37. - PubMed
    1. Than NG, Pick E, Bellyei S, et al. Functional analyses of placental protein 13/galectin-13. European Journal of Biochemistry. 2004;271(6):1065–1078. - PubMed
    1. Nicolaides KH, Bindra R, Turan OM, et al. A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound. Ultrasound in Obstetrics and Gynecology. 2006;27(1):13–17. - PubMed

LinkOut - more resources